Blue-blindness < QUICK >


You will not be able to purchase new items, however you may log in to download your old products,
or to download free products (whether you previously added them to your account or not.)
You will also be able to create a new account to log in with, in order to access the free products on the site.

We are working hard on a new system, please accept our apologies for any inconvenience in the meantime.

Blue-blindness < QUICK >

This paper explores the "lived experience" of blue-blindness by studying a patient with "unilateral tritanopia"—someone who is blue-blind in only one eye. It provides unique data on how colors in the spectrum appear to a tritanope compared to a person with normal vision.

This is the seminal work on blue-blindness. Wright identified 17 cases of tritanopia through a unique public appeal and established the fundamental luminosity and color-mixture curves for the condition. It provides the classic evidence that tritanopia is caused by the absence of blue-sensitive S-cones. blue-blindness

For a comprehensive study of "blue-blindness" (clinically known as or tritanomaly ), the best papers range from foundational clinical studies to modern medical reviews. Top Recommended Research Papers This paper explores the "lived experience" of blue-blindness

This recent open-access paper from MDPI covers the autosomal dominant inheritance pattern of tritan defects and provides up-to-date prevalence data across different global populations. Quick Comparison of Blue-Yellow Defects Impairment Level Common Confusions Tritanomaly Reduced sensitivity (S-cones) Blue/Green, Yellow/Red Tritanopia Complete absence (S-cones) Blue/Green, Yellow/Pink, Purple/Red A Global Perspective of Color Vision Deficiency - PMC - NIH Wright identified 17 cases of tritanopia through a

While congenital blue-blindness is extremely rare (less than 0.01% of the population), tritan-like defects are very common as an acquired condition. Simunovic’s comprehensive review is highly cited for its discussion of why the "blue" mechanism is more vulnerable to damage from diseases like glaucoma or diabetes.